STREAMLINE HEALTH SOLUTIONS (STRM)

Introduction

STREAMLINE HEALTH SOLUTIONS, Inc. (NASDAQ: STRM) is a healthcare technology company providing revenue cycle management and electronic health record (EHR) solutions. As of May 29, 2025, STRM shares closed at $5.0098, reflecting an increase of 118.77% on a volume of 504,079 shares.

Ticker	Exchange	Last Price	Change (%)	Volume
STRM	NAS	$5.0098	+118.77%	504,079

Corporate Structure and Leadership

• Executive Chairman: Wyche T. “Tee” Green, III
  – Joined the Board in August 2018; served as CEO from October 2019 to October 2023; became Executive Chairman in October 2023.
  – Former co-founder and CEO of Greenway Health, LLC (1998–2013).
  – Holds a Bachelor of Business Administration in Management from Auburn University.

• Employee Experience:
  – Nearly 20 years focusing on behavioral health and human services EHR platforms.
  – In-house implementation and Customer Success teams support product adoption and optimization.

Business Offerings and Recent Developments

1. RevID™ & eValuator™ (streamlinehealth.net)
   – Technology for pre-bill review to capture 100% of charges and ensure accurate coding.
   – Daily reconciliation and CMS compliance checks aimed at reducing denials and accelerating reimbursements.

2. SmartCare™ Behavioral Health EHR (streamlinehealthcare.com)
   – Enterprise-grade platform hosted on Microsoft Azure.
   – Modules for primary care, business intelligence, foster care, adoption, substance use disorder, intellectual and developmental disabilities, and community behavioral health.
   – New brand launched in April 2023, marking the company’s 20th anniversary in the behavioral health sector.

3. Hyland Acquisition of ECM Business
   – May 2025: Hyland completed the acquisition of Streamline’s enterprise content management (ECM) unit.
   – This transaction expands the Hyland Healthcare portfolio, focusing on core content services.

4. Industry Engagement
   – May 2025: Engagement at NatCon25, emphasizing the role of technology in behavioral health.

5. SEC Filings
   – May 2, 2025: Filed annual report on Form 10-K for the fiscal year ended January 31, 2025.
   – May 2, 2025: Filed NT 10-K notifying of a delay in the completion of the 10-K report.
   – May 27, 2025: Amended Form 10-K/A addressing adjustments in financial statements.

Financial and Strategic Analysis

Key Metrics (TTM as of May 2025)

• Revenue: $17.9 million
• Net Loss: $(10.16) million
• EPS (Diluted): $(2.53)
• Profit Margin: −56.75%
• Price/Sales: 0.51
• Price/Book: 0.81
• Cash on Hand: $15.85 million
• Debt/Equity: 1.07%
• Market Cap: $9.92 million

Strategic Implications

• Revenue Cycle Focus: RevID™ and eValuator™ are aimed at enhancing charge capture and coding accuracy, which are essential for cash flow in hospital and physician practice settings.
• Behavioral Health Niche: SmartCare™ supports the escalating demand for integrated mental health and human services platforms.
• Capital Allocation: The sale of the ECM business to Hyland may allow the organization to concentrate resources on core software development and market strategies.
• Compliance and Reporting: The amended filing on May 27 indicates a focus on accuracy in financial disclosures.

Market Position and Industry Context

• Competitive Landscape: Competitors include Greenway Health, Cerner, Epic, and other specialty EHR vendors.
• Industry Drivers:
  • Compliance requirements concerning coding and billing.
  • Transition toward cloud-hosted and interoperable platforms.
  • Increased funding for behavioral health services and telehealth integration.
• Challenges:
  • Ongoing pressure on profitability due to negative operating margins.
  • Challenges associated with integrating product lines following the ECM business divestiture.
  • Timing of financial reporting may influence investor confidence.

tl;dr

• On May 29, 2025, STRM shares rose 118.77% to $5.0098 amid significant trading volume.
• Recent filings include a Form 10-K (May 2) and an amended 10-K/A (May 27) for the fiscal year ended January 31, 2025.
• The sale of Streamline’s ECM business to Hyland allows the company to focus on its core RevID™ and SmartCare™ platforms.
• The company aims to continue its focus on revenue cycle management and behavioral health EHR, supported by $15.85 million in cash reserves and low levels of debt.
• Industry trends include regulatory compliance and adoption of cloud technologies; monitoring of profitability and reporting schedules is recommended.